Lantern Pharma Inc. Operating Lease Liability
Lantern Pharma Inc. (LTRN) had Operating Lease Liability of $39.72 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability $39.72K.
- 2026-03-31: Operating Lease, Liability $59.08K.
- 2025-12-31: Operating Lease, Liability $78.54K.
- 2025-09-30: Operating Lease, Liability $93.95K.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $39.72K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $59.08K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $78.54K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $93.95K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $145.04K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $59.08K 10-Q · filed 2026-05-15 | $194.93K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $243.66K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $291.24K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $218.70K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $193.58K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $234.47K 10-K · filed 2026-03-30 | |
| 2023-09-30 | $274.53K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $313.86K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $260.22K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $52.89K 10-K · filed 2025-03-27 | |
| 2022-09-30 | $92.02K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $130.71K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $168.49K 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $204.95K 10-K · filed 2024-03-18 | |
| 2021-09-30 | $240.98K 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $276.60K 10-Q · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |